Status:
COMPLETED
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
COVID19
Ophthalmopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ophthalmologic damages secondary to COVID-19 coronavirus infection are little described. The ocular involvement is probably multiple, ranging from pathologies of the anterior segment such as conjuncti...
Detailed Description
Upon discharge from hospital for COVID-19 infection (or during a telephone call for patients already discharged at the start of the study), patients will be informed of the study. An ophthalmology app...
Eligibility Criteria
Inclusion
- Patients having been hospitalized for a confirmed COVID-19 infection (CT-scanner or PCR- Polymerase chain reaction)
Exclusion
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2021
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04387292
Start Date
September 7 2020
End Date
May 15 2021
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation A de Rothschild
Paris, France, France, 75019